Source link : https://www.newshealth.biz/health-news/als-trials-fail-to-meet-key-endpointsbut-its-still-a-win/
The first platform trial for amyotrophic lateral sclerosis (ALS), which individually evaluated four experimental drugs, failed to meet key primary endpoints. Still, investigators view the trial as success, saying it marks a major milestone in ALS research because of the use of the platform model. By streamlining drug testing, this research approach could accelerate the […]
Author : News Health
Publish date : 2025-02-24 12:00:20
Copyright for syndicated content belongs to the linked Source.